Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease
{{output}}
Fluid and imaging biomarker data show that anti-amyloid (Aβ) antibodies promote the clearance of Aβ from the brains of patients with Alzheimer's disease (AD). We examined postmortem brain tissue of individuals who participated in aducanumab clinical trials ... ...
